Average Co-Inventor Count = 3.93
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Vertex Pharmaceuticals, Inc. (27 from 1,152 patents)
27 patents:
1. 8765731 - Benzimidazole analogues for the treatment or prevention of flavivirus infections
2. 8759353 - Co-crystals and pharmaceutical compositions comprising the same
3. 8618152 - Inhibitors of serine proteases, particularly HCV NS3-NS4A proteases
4. 8354419 - Benzimidazole analogues for the treatment or prevention of flavivirus infections
5. 8314141 - Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
6. 7919520 - Inhibitors of tace
7. 7608632 - Sulfonamide inhibitors of aspartyl protease
8. 7494988 - Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
9. 7485664 - Inhibitors of TACE
10. 7388017 - Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
11. 7321063 - Sulfonamide inhibitors of aspartyl protease
12. 6720335 - Sulfonamide inhibitors of aspartyl protease
13. 6617309 - Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
14. 6608067 - Inhibitors of serine proteases, particularly HCV NS3 protease
15. 6392046 - Sulfonamide inhibitors of aspartyl protease